NOVOFINE 32
Report
- Report Number
- 9681821-2012-00003
- Event Type
- Other
- Date Received
- January 31, 2012
- Date of Event
- January 1, 2011
- Report Date
- January 5, 2012
- Manufacturer
- NOVO NORDISK A/S, MEDICAL SYSTEMS
- Product Code
- FMI
- PMA / PMN Number
- K062500
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
NEEDLE BREAK IN SKIN AND NEEDED SURGERY TO REMOVE IT [INJURY ASSOCIATED WITH DEVICE]. CASE DESCRIPTION: THIS SPONTANEOUS CASE FROM THE UNIT STATES WAS REPORTED BY A CONSUMER AS "NEEDLE BROKE OFF IN THE SKIN AND NEEDED SURGERY TO REMOVE IT" AND CONCERNS A (B)(6) FEMALE PT USING NOVO FINE 32 NEEDLE FOR UNSPECIFIED PERIOD OF TIME DUE TO TYPE 2 DIABETES MELLITUS. PT'S HEIGHT: (B)(6). MEDICAL HISTORY INCLUDED TYPE 2 DIABETES MELLITUS. A PT REPORTED THAT ON ONE PARTICULAR OCCASION, SEVERAL MONTHS EARLIER, SHE NOTICED THAT A NEEDLE BROKE OFF IN HER ABDOMEN FOLLOWING AN INJECTION. SHE STATED THAT SHE REPLACED THE NEEDLE JUST PRIOR TO THE INJECTION BUT THAT SHE USUALLY LEAVES USED NEEDLES ATTACHED TO HER FLEXPEN IN BETWEEN INJECTION. SHE REPORTED THAT APPROXIMATELY TWO DAYS AFTER THE INCIDENT THE NEEDLE WAS REMOVED VIA A SURGICAL PROCEDURE PERFORMED IN HER PHYSICIAN'S OFFICE. IN ADDITION, THE PT REPORTED THAT SHE TYPICALLY "PERFORMED AIR SHOTS PRIOR TO ATTACHING A NEEDLE TO HER FLEXPEN." THE PT REPORTED THAT SHE WAS NOT CERTAIN OF THE BRAND AND SIZE OF THE NEEDLES SHE USED AT THE TIME OF THE EVENT. THE EVENT OF "INJURY ASSOCIATED WITH DEVICE" WAS REPORTED AS "RECOVERED" ON AN UNK DATE. NOTE: NOVOFINE 32 WAS CHOSEN AS SUSPECTED PRODUCT SINCE IT IS THE MOST WIDELY DISTRIBUTED NEEDLE BY NOVO NORDISK IN THE UNITED STATES. THE PT COULD NOT IDENTIFY EXACT BRAND OF NEEDLE USED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | NOVOFINE 32 | NEEDLE | FMI | NOVO NORDISK A/S, MEDICAL SYSTEMS | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Required Intervention | LEVEMIR FLEXPEN (INSULIN DETEMIR) SOLUTION FOR| INJECTION, .0024 MOL/L ONGOING. |